We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SEBA:GETTEXSkandinaviska Enskilda Banken AB Class A Analysis

Data as of 2026-05-23 - not real-time

SEK 187.03

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Skandinaviska Enskilda Banken (SEB) trades at SEK 187.0, comfortably above its 20‑day and 50‑day SMAs (~180.7 and 180.5) and just shy of the 200‑day SMA (~185.1), indicating short‑term momentum. The RSI sits at 65.8, suggesting the stock is approaching overbought levels, while a bullish MACD (line above signal) and increasing volume support continued upside toward the resistance at SEK 187.5. Fundamentally, SEB’s PE of 12.2 is well below the industry average of 16.8, and a dividend yield of 4.5% with a 55% payout ratio underscores attractive income potential. Recent Q1 results show a net profit of SEK 9.4 bn, ROE of 13.1%, and a CET1 capital ratio of 17.5%, highlighting strong profitability and capital resilience despite a 6% dip in net interest income.
The stock’s low beta (~0.30) and 30‑day volatility of roughly 15% point to modest price swings, while a solid capital buffer and disciplined leverage mitigate regulatory and credit concerns. Geographic diversification across Northern Europe and beyond introduces moderate exposure to regional economic shifts, yet the dominant SEK denomination and robust cash position keep currency risk manageable. Overall, SEB appears undervalued on a value basis, with a sustainable dividend and solid fundamentals supporting a buy‑the‑dip outlook for medium to long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at SEK 187.5
  • RSI approaching overbought territory
  • Bullish MACD with rising volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued PE relative to peers
  • Strong capital ratios (CET1 17.5%)
  • Attractive dividend yield and payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend supported by earnings
  • Low beta and modest volatility
  • Consistent profitability and solid ROE

Key Metrics & Analysis

Financial Health

Revenue Growth-6.80%
Profit Margin41.48%
P/E Ratio12.2
ROE13.63%
ROA0.75%
P/B Ratio1.7
Op. Cash FlowSEK-40988000256
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI65.8
SupportSEK 177.90
ResistanceSEK 187.52
MA 20SEK 180.71
MA 50SEK 180.48
MA 200SEK 185.11
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

GradeUndervalued
TypeValue
Dividend Yield4.54%

Risk Assessment

Beta0.30
Volatility15.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.